ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. The company was founded in February 2016, and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
10
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Ikena Oncology Inc market cap is $69.34M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ikena Oncology Inc 52 week high is $18.00 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ikena Oncology Inc 52 week low is $5.70 as of November 21, 2026.
Ikena Oncology Inc stock price today is $6.12.
Ikena Oncology Inc stock price yesterday was $5.92.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Ikena Oncology Inc's P/E ratio is -0.73.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Ikena Oncology Inc P/B ratio is 0.4734.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ikena Oncology Inc 50-day moving average is $6.75.